Fermenta Biotech Schedules Board Meeting on 5th Nov'26 for Q2 Financial Results
Fermenta Biotech Ltd 路 Intimation 路 05 Nov 2026, 5:30 am
Fermenta Biotech Schedules Board Meeting on 5th Nov'26 for Q2 Financial Results Fermenta Biotech Limited has announced that its Board of Directors will meet on 5th Nov'26 to consider and approve the standalone and consolidated unaudited financial results for the quarter and half-year ended 30th Sep'26. In compliance with insider trading regulations, the trading window for dealing in company securities, closed since 1st Oct'26, will remain shut for designated persons, insiders, and connected entities until 48 hours following the declaration of the financial results.
Original exchange filing (PDF)
More announcements from Fermenta Biotech Ltd
- Intimation regarding earnings presentation- Q2/H1FY27. 路 06 Nov 2026
- Intimation of Press release regarding unaudited financial results of H1FY27. 路 05 Nov 2026
- Intimation regarding the Board''s decision to close the Company''s wholly-owned subsidiary - Fermenta Biotech (UK) Limited. 路 05 Nov 2026
- Outcome of Board Meeting and Unaudited Financial Results (standalone and consolidated) for quarter ended September 30, 2026. 路 05 Nov 2026
- Unaudited financial results (standalone and consolidated) for the quarter ended September 30, 2026. 路 05 Nov 2026
- Fermenta Biotech Limited has submitted to the Exchange, the unaudited financial results (standalone and consolidated) for the period ended September 30, 2026. 路 05 Nov 2026
- FERMENTA BIOTECH LIMITED has informed the Exchange about Board Meeting to be held on 05-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 05 Nov 2026
- To consider and approve the unaudited financial results (standalone and consolidated) for the period ended September 30, 2026. 路 05 Nov 2026
